Business Context and Reporting Period
This Form 8-K, filed on June 22, 2022, by Zimmer Biomet Holdings, Inc. (ZBH), serves solely to recast financial information from its Annual Report on Form 10-K for the fiscal year ended December 31, 2021. The recasting reflects the March 1, 2022, spinoff of the company's spine and dental businesses into a new public entity, ZimVie Inc. Consequently, historical results for these divested segments are now presented as discontinued operations in the recast financial statements.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a procedural notice to update the presentation of prior financial data rather than reporting new operational results. The recast balance sheets as of December 31, 2021, and 2020, now classify assets and liabilities associated with the spine and dental businesses as assets and liabilities of discontinued operations.
Material Changes Versus Prior Period
The primary material change is the reclassification of the spine and dental business segments from continuing operations to discontinued operations in the 2021 Form 10-K. This adjustment affects the following sections of the original report:
- Part II, Item 7: Management's Discussion and Analysis of Financial Condition and Results of Operations.
- Part II, Item 7A: Quantitative and Qualitative Disclosures about Market Risk.
- Part II, Item 8: Financial Statements and Supplementary Data.
- Part IV, Item 15(a)(2): Financial Statement Schedule.
Except for these recasts related to the spinoff, no other revisions have been made to the 2021 Form 10-K to reflect subsequent events or developments.
Guidance, Outlook, and Risks
This filing does not contain new guidance, outlook, or management commentary regarding future performance. The document explicitly states that the recast information in Exhibit 99.1 is not an amendment or restatement of the 2021 Form 10-K but rather a presentation adjustment. Investors are directed to subsequent filings, including the Form 10-Q for the quarter ended March 31, 2022, and other Current Reports on Form 8-K, for updates on forward-looking statements, risks, and developments occurring after the original 2021 Form 10-K filing.
Investor Verification Checklist
- Verify the specific financial impact of the discontinued operations by reviewing Exhibit 99.1 attached to this filing.
- Confirm that the recast financial statements align with the March 1, 2022, spinoff of ZimVie Inc.
- Review the Form 10-Q for the quarter ended March 31, 2022, for updated operational results and forward-looking statements not covered in this recast.
- Ensure that any analysis of ZBH's continuing operations excludes the historical results of the spine and dental businesses.